BioCardia
Overview
Products
Pipeline
Publications & Talks
Patents
Press & News
Scientific Advisors

Publications & Talks

Shortcuts: 2008   2007   2006   2005   2004   2003   2002   2001   2000

2008
PDF Transendocardial Autologous Bone Marrow in Chronic Myocardial Infarction using a Helical Needle Catheter, Two Year Follow-up in an Open-Label, Non-Randomized, Pilot Study (the TABMMI study) Presented at the 2008 World Congress of Cardiology Abstracts, Buenos Aires, Argentina, May 2008.
PDF Transendocardial Autologous Bone Marrow Cells in Chronic Myocardial Infarction using Helical Needle Catheter: Two-Year Followup in an Open-Label, Non-Randomized, Single-Center Pilot Study (the TABMMI study) By Luis M. de la Fuente, M.D., Simon H. Stertzer, M.D., Eduardo Peñaloza, M.D., Julio Argentieri, M.D., Jorge Miano, M.D., Benjamin Koziner, M.D., Christian Bilos, M.D., Licia Battaglia, Ph.D., Graciela Lucero, Ph.D., Jessica Stertzer, Didier Rouy, M.D., Peter A. Altman, Ph.D. Presented at the Cardiovascular Revascularization Therapies (CRT) conference, Washington, D.C., February 12, 2008.
PDF Reporter Gene Imaging Following Percutaneous Delivery in Swine: Moving Toward Clinical Applications. By Martin Rodriguez-Porcel,M.D., Todd J. Brinton, M.D., Ian Y. Chen, MSE, Olivier Gheysens, M.D., Jennifer Lyons, Fumiaki Ikeno, M.D., Jürgen K. Willmann, M.D., Lily Wu, M.D., Ph.D., Joseph C. Wu, M.D., Ph.D., Alan C. Yeung, M.D., Paul Yock, M.D., and Sanjiv J. Gambhir, M.D., Ph.D. Published in the Journal of the American College of Cardiology, February 5, 2008.

2007
Poster American Heart Association Council on Basic Cardiovascular Sciences, July 30-Aug 2, Keystone, CO: "Transendocardial Catheter Delivery of Artificial Biopolymer Matrices for Enhanced Cell Retention in Cardiovascular Cell Based Therapy"
PDF Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study) - American Heart Journal, July 2007
Poster The Stem Cell Meeting, March 2007, San Francisco, CA: “Transendocardial Autologous Bone Marrow Cells in Chronic Myocardial Infarction Using Helical Needle Catheter, Six Month Follow-up in an Open-Label, Non-Randomized, Single-Center Pilot Study of an Adult Stem Cell Stimulation Program (the TABMMI Study)” by Luis De La Fuente, et. al.
Invited Talk Percutaneous Endovascular Therapeutics, April 2007, Buenos Aires, Argentina: “Percutaneous Cardiovascular Cell Therapy”
Talk 2nd Annual Symposium on Cardiovascular Cell Therapy 2007:  Featured in ‘Clinical Studies II: Chronic Left Ventricular Dysfunction “Bone Marrow Mononuclear Cells: The Focus – CHF Study” by Dr. Emerson Perin

2006
PDF Six Month Follow-up after Transendocardial Autologous Fractionated Bone Marrow Shows Increased Ejection Fraction in Patients with Ventricular Dysfunction After Chronic Myocardial Infarction, an Open-Label, Non-Randomized, Single-Center Study (the TABMMI study)
PDF Catheter-based delivery of cells to the heart
PDF Percutaneous delivery and non-invasive imaging of gene and cell therapy in a porcine model
Talk Transcatheter Cardiovascular Therapeutics 2006:  Featured in “Novel Myocardial Preservation Therapies” in Plenary Session 15: Interventional Hot Topics V by Dr. Bill O’Neil
Talk Transcatheter Cardiovascular Therapeutics 2006:  Featured in “Isolation and Potential of Cardiac-Derived Stem Cells” in Session on Myocardial Repair Strategies: From Local Responses to Cell Therapy to Tissue Engineering by Dr. Joshua Hare.
Talk Transcatheter Cardiovascular Therapeutics 2006:  Featured in “Cell Retention” Routes of Cell Delivery by Dr. Dara L. Kraitchman.

2005
PDF Coronary intervention, Vol. 1 No. 3 2005, pp. 95-97 (Japanese)
PDF Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction, PNAS, Aug., 2005

2004
PDF Cardiac Repair with Mesenchymal Stem Cells following Myocardial Infarction in Pigs
PDF American Heart Association Scientific Sessions 2004:  Featured in: "Overview of Cell Based Therapies," by Dr. Joshua Hare, Baltimore, MD.
PDF Transcatheter Cardiovascular Therapeutics 2004:  Featured in “Intracoronary vs. Percutaneous Endomyocardial Delivery of Porcine Mesenchymal Stem Cells to Areas of Myocardial Infarction,” by Dr. Eric Price, Stanford University.

2003
PDF In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction
PDF Percutaneous Endocardial Versus Selective Coronary Venous Cellular Delivery: Comparison of Transplant Efficiency, Distribution, and Efficacy in Reducing Infarct Size and Improving Myocardial Function
PDF Catheter Based Percutaneous Cardiomyoplasty Using Allogenic Bone Marrow Derived Mesenchymal Stem Cells
PDF How Well Does A Helical Needle Catheter Deliver FGF-2?
PDF Intramyocardial Pharmacokinetics of Cell Sized Particles after Local Transendocardial Delivery in Swine
PDF Exploring Heart Lymphatics in Local Drug Delivery

2002
PDF The Helical Infusion Catheter: First Clinical Evaluation for Local Intramyocardial Delivery of Therapeutics
PDF Preparation and Administration of Biodegradable Drug Delivery Microspheres into Porcine Myocardium with a Helical Injection Catheter
PDF Interventional Cellular Cardiomyoplasty by Transendocardial Implantation of Mesenchymal Stem Cells
HTML Delivery of Plasmid to the Myocardium Using Direct Injection Via Needle or Helical Needle-Catheter
HTML Percutaneous Endocardial Infusion of Plasmids Using Helical Needle Catheter

2001
HTML Percutaneous Intramyocardial Delivery is an Efficient Modality for Local Myocardial Treatment
HTML Transcatheter Delivery of Therapeutic Formulations For Percutaneous Intramyocardial Delivery
HTML Enhanced Local Uptake of Genetic Material Through Intramyocardial Electroporation with Helix Infusion Electrode
HTML Evaluation of the Percutaneous Intramyocardial Injection for Local Myocardial Treatment

2000
HTML Feasibility Studies of Percutaneous Mammalian Cell Delivery for Local Myocardial Treatment

1999
HTML Therapeutic Angiogenesis Using Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Using Various Delivery Strategies